Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001193125-26-054799·Bain Capital Life Sciences Fund, L.P.
Schedule 13G ownership disclosure
PHARVARIS N V
Ordinary Shares, Euro 0.12 par value per share · CUSIP: N69605108
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Bain Capital Life Sciences Fund, L.P.
Shares: 1,640,817 · Class: 2.5%
- BCIP Life Sciences Associates, LP
Shares: 167,950 · Class: 0.3%
- Bain Capital Life Sciences Opportunities III, LP
Shares: 993,314 · Class: 1.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-26-054799
- Form type
- SCHEDULE 13G/A
- Filer
- Bain Capital Life Sciences Fund, L.P.
- CIK
- CIK 1687968
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership